cagrilintide semaglutide combination phase 3 2024 Novo Nordisk's CagriSema 2.4 mg / 2.4 mg demonstrated significant reduction in HbA1c and weight across multiple studies in the REIMAGINE program presented at ADA 2026 Three new phase 3 REIMAGINE

If we feature your Disaster Averted in our Diabetes Clinical Mastery Series e-newsletter, you will receive a $25 gift card

Paul Woodbury clinic: We typically recommend weekly subcutaneous injections for most men because they provide: Greater dose precision Rapid adjustability Predictable serum response Reduced variability Topical therapy may be appropriate in selected cases, particularly when injection aversion is significant

Just continue your regular dosing schedule

Hydration: water and herbal teas instead of sugary drinks

Sergey Terushkin, MD, FACS The most successful patients are rarely focused on finding a shortcut